Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities
Eun-mi Yu,1 Min Woo Hwang,2 Jeanny B Aragon-Ching1 1GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA; 2Department of Internal Medicine, Inova Fairfax Hospital, Fairfax, VA, USACorrespondence: Jeanny B Aragon-Ching, Clinical Program Director of Genitourinary Cancers, Inova Schar Ca...
Main Authors: | Yu EM, Hwang MW, Aragon-Ching JB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Research and Reports in Urology |
Subjects: | |
Online Access: | https://www.dovepress.com/mechanistic-insights-on-localized-to-metastatic-prostate-cancer-transi-peer-reviewed-fulltext-article-RRU |
Similar Items
-
Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases
by: Yukiyoshi Hirayama, et al.
Published: (2022-11-01) -
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape
by: Ashaar Al-Akhras, et al.
Published: (2024-01-01) -
Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib
by: Riko Ikeda, et al.
Published: (2024-03-01) -
RETRACTED: New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
by: Neha Thakur, et al.
Published: (2023-08-01) -
Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
by: Xiangyu Chen, et al.
Published: (2023-10-01)